WallStreetZenWallStreetZen

NASDAQ: PCRX
Pacira Biosciences Inc Stock Ownership - Who owns Pacira Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pacira Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lauren RikerSenior Vice President Finance2026-02-024,000$20.81
$83.24kSell
Kristen WilliamsChief Administrative Officer2026-02-0213,137$20.53
$269.70kSell
Frank D. LeeChief Executive Officer2026-01-3041,488$20.54
$852.16kSell
Jonathan SloninChief Medical Officer2026-01-306,168$20.54
$126.69kSell
Lauren RikerSenior Vice President Finance2026-01-302,751$20.54
$56.51kSell
Brendan TeehanChief Commercial Officer2026-01-305,182$20.54
$106.44kSell
Kristen WilliamsChief Administrative Officer2026-01-3017,134$20.54
$351.93kSell
Lauren RikerSenior Vice President Finance2026-01-051,416$24.24
$34.32kSell
Jonathan SloninChief Medical Officer2026-01-02381$24.46
$9.32kSell
Lauren RikerSenior Vice President Finance2026-01-02159$24.46
$3.89kSell

1 of 3

PCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCRX insiders and whales buy or sell their stock.

PCRX Shareholders

What type of owners hold Pacira Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.42%7,064,280$153.79MInstitution
Orbimed Advisors LLC12.26%5,274,941$114.84MInsider
Vanguard Group Inc11.19%4,812,955$104.78MInstitution
Andreas Wicki9.50%4,085,359$88.94MInsider
Carl L. Gordon6.58%2,828,941$61.59MInsider
Vaughn M. Kailian6.49%2,790,479$60.75MInsider
Mpm Bioventures IV Qp LP6.49%2,790,479$60.75MInsider
Hbm Healthcare Investments Cayman Ltd5.19%2,233,993$48.63MInsider
Dimensional Fund Advisors LP4.53%1,950,013$42.45MInstitution
Renaissance Technologies LLC4.38%1,884,001$41.01MInstitution

1 of 3

PCRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCRX59.90%40.10%Net SellingNet Selling
CRON8.94%49.08%Net SellingNet Selling
TLRY6.73%17.71%Net BuyingNet Buying
ESPR44.06%17.28%Net SellingNet Selling
IRWD54.31%39.89%Net SellingNet Selling
View Top Pharmaceutical Stocks

Pacira Biosciences Stock Ownership FAQ

Who owns Pacira Biosciences?

Pacira Biosciences (NASDAQ: PCRX) is owned by 81.38% institutional shareholders, 54.48% Pacira Biosciences insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Pacira Biosciences shareholder, owning 5.27M shares representing 12.26% of the company. Orbimed Advisors LLC's Pacira Biosciences shares are currently valued at $119.95M.

If you're new to stock investing, here's how to buy Pacira Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.